Cart
sales@molnova.com
NSC5844
CAS No. 140926-75-6
NSC5844 ( NSC5844; NSC-5844; NSC 5844; RE640 )
Catalog No. M17281 CAS No. 140926-75-6
NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | Get Quote |
|
| 10MG | 80 | Get Quote |
|
| 25MG | 132 | Get Quote |
|
| 50MG | 196 | Get Quote |
|
| 100MG | 291 | Get Quote |
|
| 200MG | 435 | Get Quote |
|
| 500MG | 698 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNSC5844
-
NoteResearch use only, not for human use.
-
Brief DescriptionNSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
-
DescriptionNSC5844, also known as RE640, is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic properties.
-
SynonymsNSC5844; NSC-5844; NSC 5844; RE640
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorCCR1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number140926-75-6
-
Formula Weight383.27
-
Molecular FormulaC20H16Cl2N4
-
Purity98%
-
Solubility——
-
SMILESc1cc2c(ccnc2cc1Cl)NCCNc1c2ccc(cc2ncc1)Cl
-
Chemical NameN,N'-bis(7-chloroquinolin-4-yl)ethane-1,2-diamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang H, et al. Biomed PharmacOthers. 2008 Feb;62(2):65-9.
molnova catalog
related products
-
Leniolisib
A novel potent and selective PI3Kδ inhibitor with biochemical IC50 of 11 nM; displays >20-fold, 40-fold, and 200-fold selectivity over PI3Kα, PI3Kβ, and PI3Kγ, respectively.
-
BPR1J-097 hydrochlor...
BPR1J-097, a new-type small molecule FLT-3 inhibitor(IC50=11±7 nM), is with great anti-tumor activities in vivo.
-
3-Methyladenine
A selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 uM and 60 uM in HeLa cells.
